Next, we determined if differentially expressed genes identified from RNA-seq analysis of IRE1αWT vs. IRE1αKO tumor cells harvested from HKP1 tumors could be exploited to develop an IRE1α-dependent gene signature that could predict outcome in human NSCLC. This evidence concerns the gene ERN1 and neoplasm.